This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: H. Lee Moffitt Cancer Center and Research Institute, Inc., University of South Florida, Provectus Pharmatech, Inc. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 312 
2 out of 1,990 
1 out of 26 Years Active: 2018-2025
Title: Innovator Hao Liu: Pioneering Cancer Immunotherapy
Introduction
Hao Liu, a prominent inventor based in Tampa, FL, has made significant contributions to the field of cancer immunotherapy. With two patents to his name, Liu is at the forefront of research that aims to enhance the efficacy of cancer treatments through innovative approaches using immune cells.
Latest Patents
Liu's recent patents reflect groundbreaking methodologies in the expansion and application of tumor-infiltrating lymphocytes. The first patent, titled "Tumor-infiltrating lymphocytes for adoptive cell therapy," details compositions and methods for ex vivo expansion of these lymphocytes aimed at improving adoptive cell therapy (ACT). This patent also presents techniques for identifying agents that facilitate the expansion of tumor-infiltrating lymphocytes, further underscoring his dedication to advancing cancer treatment options.
The second patent, "Method of ex vivo enhancement of immune cell activity for cancer immunotherapy with a small molecule ablative compound," introduces a cancer immunotherapy technique involving the isolation of 'induced immune anticancer agents.' This process entails the intralesional administration of a halogenated xanthene tumor-ablative compound into solid tumors, subsequently allowing for the collection and enrichment of tumor-specific immune anticancer agents that can be reintroduced into the host or another suitable recipient.
Career Highlights
Hao Liu's career includes significant positions at esteemed research institutions. He has been associated with the H. Lee Moffitt Cancer Center and Research Institute, a leading center dedicated to cancer research and treatment. Additionally, Liu has worked with Provectus Pharmatech, a company known for its innovative approaches to cancer therapeutics. His expertise and research have positioned him as a key figure in the development of novel cancer treatments.
Collaborations
Throughout his career, Liu has collaborated with notable colleagues, including Amod A Sarnaik and Shari Pilon-Thomas. These partnerships have enriched his research and contributed to the advancement of cancer immunotherapy solutions.
Conclusion
Hao Liu's innovative approaches to cancer immunotherapy, demonstrated through his patents and collaborative efforts, signify a promising future in the realm of cancer treatment. His work not only aims to improve patient outcomes but also represents a vital step forward in the ongoing battle against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile